6-phosphogluconic acid has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adán-Ladrón de Guevara, A; Gallardo-Pérez, JC; Marín-Hernández, A; Moreno-Sánchez, R; Rodríguez-Enríquez, S | 1 |
| Gallardo-Pérez, JC; Marín-Hernández, A; Moreno-Sánchez, R; Rivero-Segura, NA; Rodríguez-Enríquez, S | 1 |
2 other study(ies) available for 6-phosphogluconic acid and Breast Cancer
| Article | Year |
|---|---|
HPI/AMF inhibition halts the development of the aggressive phenotype of breast cancer stem cells.
Topics: Breast Neoplasms; Cell Hypoxia; Cell Movement; Cell Proliferation; Doxorubicin; Epithelial-Mesenchymal Transition; Female; Gluconates; Humans; Intracellular Signaling Peptides and Proteins; MCF-7 Cells; Neoplasm Metastasis; Neoplastic Stem Cells; Paclitaxel; RNA, Small Interfering; Sugar Phosphates; Sulfonamides | 2017 |
GPI/AMF inhibition blocks the development of the metastatic phenotype of mature multi-cellular tumor spheroids.
Topics: 3T3 Cells; Adult; Aged; Aged, 80 and over; Animals; Blotting, Western; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Movement; Cell Proliferation; Cross-Sectional Studies; Cytokines; Epithelial-Mesenchymal Transition; Female; Gluconates; Glucose-6-Phosphate Isomerase; Humans; Lactic Acid; MCF-7 Cells; Mice; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Phenotype; Spheroids, Cellular; Sugar Phosphates | 2014 |